Literature DB >> 33271080

Cardiovascular risk factors in China: a nationwide population-based cohort study.

Xi Li1, Chaoqun Wu2, Jiapeng Lu3, Bowang Chen3, Yichong Li4, Yang Yang2, Shengshou Hu1, Jing Li5.   

Abstract

BACKGROUND: It is estimated that 4 million deaths are due to cardiovascular diseases each year in China. Comprehensive understanding about modifiable risk factors and how the risk differs across regions is needed to inform public health policies. We aimed to examine the geographical profile of cardiovascular disease risk across China.
METHODS: In this study, we analysed data from a nationwide, population-based screening project, which covered 152 rural counties and 100 urban districts from 31 provinces in China. Between Sept 1, 2015, and Nov 30, 2019, standardised measurements were taken from participants aged 35-75 years who had lived in the region for at least 6 of the preceding 12 months to collect information on blood pressure, blood lipids, blood glucose, physical activity, tobacco smoking, alcohol use, overweight or obesity, and intake frequencies of fruits, vegetables, whole grains, legumes, and red meat. Individuals with a high risk of cardiovascular disease were identified according to medical history and WHO risk prediction charts.
FINDINGS: 983 476 individuals were included in this study. Among the participants included, 10·3% (95% CI 10·2-10·3) had a high cardiovascular disease risk after standardising age and sex, with a range of 3·1-24·9% across counties or districts. Among the seven regions in mainland China, the prevalence of high risk of cardiovascular disease was relatively high in northeast China (12·6% [12·4-12·8]) and north China (11·4% [11·3-11·6]), whereas it was low in south China (8·0% [7·8-8·2]). The geographical profiles of the 12 major cardiovascular disease risk factors were different. We found that the regions with high cardiovascular disease risk were facing challenges such as obesity and high blood pressure (north China) and consumption of unhealthy non-staple food (low intake of fruits and vegetables or high intake of red meat; northeast China). By contrast, south China-the region with the lowest cardiovascular disease risk-had the highest prevalence of unhealthy staple food (low intake of whole grains and beans), abnormal metabolism (glucose and lipid), and low physical activity in the country.
INTERPRETATION: Risk for cardiovascular diseases varies geographically, and the major contributing risk factors are different across regions in China. Hence, geographically targeted interventions are needed to mitigate the risk and reduce the burden in such a vast country. FUNDING: Ministry of Science and Technology, Ministry of Finance, and National Health Commission of China.
Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY NC ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33271080     DOI: 10.1016/S2468-2667(20)30191-2

Source DB:  PubMed          Journal:  Lancet Public Health


  27 in total

Review 1.  HDAC4 Inhibitors as Antivascular Senescence Therapeutics.

Authors:  Chuoji Huang; Zhongxiao Lin; Xiaoyan Liu; Qian Ding; Jianghong Cai; Zhongyi Zhang; Peter Rose; Yi Zhun Zhu
Journal:  Oxid Med Cell Longev       Date:  2022-06-29       Impact factor: 7.310

2.  Combined Effects of Obesity and Dyslipidaemia on the Prevalence of Diabetes Amongst Adults Aged ≥45 Years: Evidence from a Nationally Representative Cross-Sectional Study.

Authors:  Simin Zhang; Donghan Sun; Xiaoyi Qian; Li Li; Wenwen Wu
Journal:  Int J Environ Res Public Health       Date:  2022-06-30       Impact factor: 4.614

Review 3.  Implications of the heterogeneity between guideline recommendations for the use of low dose aspirin in primary prevention of cardiovascular disease.

Authors:  Xiao-Ying Li; Li Li; Sang-Hoon Na; Francesca Santilli; Zhongwei Shi; Michael Blaha
Journal:  Am J Prev Cardiol       Date:  2022-06-06

4.  Circular RNA circ_0001445 alleviates the ox-LDL-induced endothelial injury in human primary aortic endothelial cells through regulating ABCG1 via acting as a sponge of miR-208b-5p.

Authors:  Zhihua Yang; Xing Liang; Lixia Yang
Journal:  Gen Thorac Cardiovasc Surg       Date:  2022-04-07

5.  Relationship Between Metabolic Syndrome and Cognitive Function: A Population-Based Study of Middle-Aged and Elderly Adults in Rural China.

Authors:  Changqing Zhan; Qiao Wang; Jie Liu; Lei Wang; Zongsheng Chen; Hongbo Pang; Jun Tu; Xianjia Ning; Jinghua Wang; Shizao Fei
Journal:  Diabetes Metab Syndr Obes       Date:  2021-04-30       Impact factor: 3.168

6.  Geographic and Sociodemographic Disparities in Cardiovascular Risk in Burkina Faso: Findings from a Nationwide Cross-Sectional Survey.

Authors:  Kadari Cisse; Sekou Samadoulougou; Mady Ouedraogo; Bruno Bonnechère; Jean-Marie Degryse; Seni Kouanda; Fati Kirakoya-Samadoulougou
Journal:  Risk Manag Healthc Policy       Date:  2021-07-07

7.  Sex differences in the associations between adiposity distribution and cardiometabolic risk factors in overweight or obese individuals: a cross-sectional study.

Authors:  Yide Yang; Ming Xie; Shuqian Yuan; Yuan Zeng; Yanhui Dong; Zhenghe Wang; Qiu Xiao; Bin Dong; Jun Ma; Jie Hu
Journal:  BMC Public Health       Date:  2021-06-26       Impact factor: 3.295

8.  Changes in Six-Month Prevalence of Circulatory System Diseases among People Aged 20 Years and Older between 2013 and 2018 in Hunan, China.

Authors:  Zhenzhen Rao; Junjie Hua; Ruotong Li; Yanhong Fu; Jie Li; Wangxin Xiao; Jieyi He; Guoqing Hu
Journal:  Int J Environ Res Public Health       Date:  2021-03-05       Impact factor: 3.390

9.  Factors Related to Blood Pressure Response after Community-Based Exercise Program in the Elderly Population.

Authors:  Yi-Pin Wang; Kuo-Wei Tseng; Meng-Hui Lin; Mei-Wun Tsai
Journal:  Int J Environ Res Public Health       Date:  2021-03-18       Impact factor: 3.390

10.  Validating World Health Organization cardiovascular disease risk charts and optimizing risk assessment in China.

Authors:  Jianxin Li; Fangchao Liu; Xueli Yang; Jie Cao; Shufeng Chen; Jichun Chen; Keyong Huang; Chong Shen; Xiaoqing Liu; Ling Yu; Yingxin Zhao; Xianping Wu; Liancheng Zhao; Xigui Wu; Ying Li; Dongsheng Hu; Jianfeng Huang; Xiangfeng Lu
Journal:  Lancet Reg Health West Pac       Date:  2021-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.